Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.

Published on May 1, 2019in European Journal of Radiology2.687
· DOI :10.1016/J.EJRAD.2019.03.003
Harpreet Hyare6
Estimated H-index: 6
(UCL Institute of Neurology),
Louise Rice2
Estimated H-index: 2
+ 5 AuthorsJeremy Rees31
Estimated H-index: 31
(UCL Institute of Neurology)
Abstract Background and purpose There is increasing evidence that many IDH wildtype (IDHwt) astrocytomas have a poor prognosis and although MR features have been identified, there remains diagnostic uncertainty in the clinic. We have therefore conducted a comprehensive analysis of conventional MR features of IDHwt astrocytomas and performed a Bayesian logistic regression model to identify critical radiological and basic clinical features that can predict IDH mutation status. Materials and methods 146 patients comprising 52 IDHwt astrocytomas (19 WHO Grade II diffuse astrocytomas (A II) and 33 WHO Grade III anaplastic astrocytomas (A III)), 68 IDHmut astrocytomas (53 A II and 15 A III) and 26 GBM were studied. Age, sex, presenting symptoms and Overall Survival were recorded. Two neuroradiologists assessed 23 VASARI imaging descriptors of MRI features and the relation between IDH mutation status and MR and basic clinical features was modelled by Bayesian logistic regression, and survival by Kaplan-Meier plots. Results The features of greatest predictive power for IDH mutation status were, age at presentation (OR = 0.94 +/−0.03), tumour location within the thalamus (OR = 0.15 +/−0.25), involvement of speech receptive areas (OR = 0.21 +/−0.26), deep white matter invasion of the brainstem (OR = 0.10 +/−0.32), and T1/FLAIR signal ratio (OR = 1.63 +/−0.64). A logistic regression model based on these five features demonstrated excellent out-of-sample predictive performance (AUC = 0.92 +/−0.07; balanced accuracy 0.81 +/−0.09). Stepwise addition of further VASARI variables did not improve performance. Conclusion Five demographic and VASARI features enable excellent individual prediction ofIDH mutation status, opening the way to identifying patients with IDHwt astrocytomas for earlier tissue diagnosis and more aggressive management.
📖 Papers frequently viewed together
57 Citations
44 Citations
10 Authors (Biqi Zhang, ..., Raymond Y. Huang)
140 Citations
#1Rachel L. Delfanti (UCSD: University of California, San Diego)H-Index: 5
#2David Piccioni (UCSD: University of California, San Diego)H-Index: 23
Last. Nikdokht Farid (UCSD: University of California, San Diego)H-Index: 17
view all 15 authors...
The 2016 World Health Organization Classification of Tumors of the Central Nervous System incorporates the use of molecular information into the classification of brain tumors, including grade II and III gliomas, providing new prognostic information that cannot be delineated based on histopathology alone. We hypothesized that these genomic subgroups may also have distinct imaging features. A retrospective single institution study was performed on 40 patients with pathologically proven infiltrati...
51 CitationsSource
#1Hao Zhou (CSU: Central South University)H-Index: 4
#2Martin Vallières (McGill University)H-Index: 18
Last. Li YangH-Index: 11
view all 13 authors...
Background: Previous studies have shown that MR imaging features can be used to predict survival and molecular profile of glioblastoma. However, no study of a similar type has been performed on lower-grade gliomas (LGGs). Methods: Presurgical MRIs of 165 patients with diffuse low- and intermediate-grade gliomas (histological grades II and III) were scored according to the Visually Accessible Rembrandt Images (VASARI) annotations. Radiomic models using automated texture analysis and VASARI featur...
162 CitationsSource
#1Kevin Leu (UCLA: University of California, Los Angeles)H-Index: 15
#2Garrett A. Ott (UCLA: University of California, Los Angeles)H-Index: 1
Last. Benjamin M. Ellingson (UCLA: University of California, Los Angeles)H-Index: 52
view all 9 authors...
The value of perfusion and diffusion-weighted MRI in differentiating histological subtypes according to the 2007 WHO glioma classification scheme (i.e. astrocytoma vs. oligodendroglioma) and genetic subtypes according to the 2016 WHO reclassification (e.g. 1p/19q co-deletion and IDH1 mutation status) in WHO grade II and III diffuse gliomas remains controversial. In the current study, we describe unique perfusion and diffusion MR signatures between histological and genetic glioma subtypes. Sixty-...
77 CitationsSource
#1Maciej A. Mazurowski (Duke University)H-Index: 25
#2Kal Clark (Duke University)H-Index: 7
Last. Ashirbani Saha (Duke University)H-Index: 18
view all 6 authors...
Recent studies identified distinct genomic subtypes of lower-grade gliomas that could potentially be used to guide patient treatment. This study aims to determine whether there is an association between genomics of lower-grade glioma tumors and patient outcomes using algorithmic measurements of tumor shape in magnetic resonance imaging (MRI). We analyzed preoperative imaging and genomic subtype data from 110 patients with lower-grade gliomas (WHO grade II and III) from The Cancer Genome Atlas. C...
38 CitationsSource
#1Amélie Darlix (French Institute of Health and Medical Research)H-Index: 15
#2Jeremy DeverdunH-Index: 11
Last. Hugues Duffau (French Institute of Health and Medical Research)H-Index: 102
view all 12 authors...
Diffuse low-grade gliomas (DLGG) prognosis is variable, depending on several factors, including the isocitrate dehydrogenase (IDH) mutation and the 1p19q codeletion. A few studies suggested associations between these parameters and tumor radiological characteristics including topography. Our aim was analyzing the correlations between the IDH and 1p19q statuses and the tumor intracerebral distribution (at the lobar and voxel levels), volume, and borders. We conducted a retrospective, monocentric ...
36 CitationsSource
#1Wen-Li Tan (SHU: Shanghai University)H-Index: 3
#2Ji Xiong (Fudan University)H-Index: 11
Last. Daoying Geng (Fudan University)H-Index: 11
view all 6 authors...
Purpose To investigate the value of dynamic susceptibility contrast (DSC) magnetic resonance imaging (MRI) in the noninvasive evaluation of isocitrate dehydrogenase (IDH) 1 gene status in astrocytoma. Materials and Methods The preoperative DSC MRI data of 91 lesions with pathologically confirmed astrocytoma were retrospectively analyzed. MR examination was performed on a 3T MRI scanner. The normalized maximum ratios of relative cerebral blood volume (rCBV ratio) of tumor parenchyma were measured...
40 CitationsSource
#1Biqi ZhangH-Index: 5
#2Ken ChangH-Index: 20
Last. Raymond Y. HuangH-Index: 29
view all 10 authors...
High-grade gliomas with mutations in the isocitrate dehydrogenase (IDH) gene family confer longer overall survival relative to their IDH-wild-type counterparts. Accurate determination of the IDH genotype preoperatively may have both prognostic and diagnostic value. The current study used a machine-learning algorithm to generate a model predictive of IDH genotype in high-grade gliomas based on clinical variables and multimodal features extracted from conventional MRI.Preoperative MRIs were obtain...
140 CitationsSource
#1Jiun-Lin YanH-Index: 8
#2Anouk van der Hoorn (University of Cambridge)H-Index: 14
Last. Stephen J. Price (University of Cambridge)H-Index: 31
view all 6 authors...
OBJECTIVE Diffusion tensor imaging (DTI) has been shown to detect tumor invasion in glioblastoma patients and has been applied in surgical planning. However, the clinical value of the extent of resection based on DTI is unclear. Therefore, the correlation between the extent of resection of DTI abnormalities and patients' outcome was retrospectively reviewed. METHODS A review was conducted of 31 patients with newly diagnosed supratentorial glioblastoma who underwent standard 5-aminolevulinic acid...
45 CitationsSource
#1David N. Louis (Harvard University)H-Index: 138
#2Arie Perry (UCSF: University of California, San Francisco)H-Index: 105
Last. David W. Ellison (St. Jude Children's Research Hospital)H-Index: 93
view all 10 authors...
The 2016 World Health Organization Classification of Tumors of the Central Nervous System is both a conceptual and practical advance over its 2007 predecessor. For the first time, the WHO classification of CNS tumors uses molecular parameters in addition to histology to define many tumor entities, thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era. As such, the 2016 CNS WHO presents major restructuring of the diffuse gliomas, medulloblastomas and oth...
7,038 CitationsSource
#1Daniel J. Brat (Emory University)H-Index: 94
#2Roel G.W. VerhaakH-Index: 55
Last. Jianan ZhangH-Index: 6
view all 307 authors...
BACKGROUND: Diffuse low-grade and intermediate-grade gliomas (which together make up the lower-grade gliomas, World Health Organization grades II and III) have highly variable clinical behavior that is not adequately predicted on the basis of histologic class. Some are indolent; others quickly progress to glioblastoma. The uncertainty is compounded by interobserver variability in histologic diagnosis. Mutations in IDH, TP53, and ATRX and codeletion of chromosome arms 1p and 19q (1p/19q codeletio...
1,636 CitationsSource
Cited By7
Glioma is a common malignant brain tumor with distinct survival among patients. The isocitrate dehydrogenase (IDH) gene mutation provides critical diagnostic and prognostic value for glioma. It is of crucial significance to non-invasively predict IDH mutation based on pre-treatment MRI. Machine learning/deep learning models show reasonable performance in predicting IDH mutation using MRI. However, most models neglect the systematic brain alterations caused by tumor invasion, where widespread inf...
#1Yeo Kyung Nam (UOU: University of Ulsan)H-Index: 1
#2Ji Eun Park (UOU: University of Ulsan)H-Index: 18
Last. Ho Sung Kim (UOU: University of Ulsan)H-Index: 36
view all 7 authors...
To determine reproducible MRI parameters predictive of molecular subtype and risk stratification in glioma and develop a structured reporting system. All study patients were initially diagnosed with glioma, 141 from the Cancer Genome Atlas and 131 from our tertiary institution, as training and validation sets, respectively. Images were analyzed by three neuroradiologists with 1–7 years of experience. MRI features including contrast enhancement pattern, necrosis, margin, edema, T2/FLAIR mismatch,...
1 CitationsSource
#1Arian Lasocki (Peter MacCallum Cancer Centre)H-Index: 11
#2Mustafa AnjariH-Index: 7
Last. Stefanie Thust (UCL Institute of Neurology)H-Index: 7
view all 4 authors...
Molecular parameters have become integral to glioma diagnosis. Much of radiogenomics research has focused on the use of advanced MRI techniques, but conventional MRI sequences remain the mainstay of clinical assessments. The aim of this research was to synthesize the current published data on the accuracy of standard clinical MRI for diffuse glioma genotyping, specifically targeting IDH and 1p19q status. A systematic search was performed in September 2019 using PubMed and the Cochrane Library, i...
3 CitationsSource
BACKGROUND AND PURPOSE Studies consistently report lower ADC values in isocitrate dehydrogenase (IDH) wild-type gliomas than in IDH mutant tumors, but their methods and thresholds vary. This research aimed to compare volumetric and regional ADC measurement techniques for glioma genotyping, with a focus on IDH status prediction. MATERIALS AND METHODS Treatment-naive World Health Organization grade II and III gliomas were analyzed by 3 neuroradiologist readers blinded to tissue results. ADC minimu...
1 CitationsSource
#1Raphael Meier (University of Bern)H-Index: 16
#2Aurélie Pahud de Mortanges (University of Bern)
Last. Urspeter Knecht (University of Bern)H-Index: 10
view all 4 authors...
Objectives To identify qualitative VASARI (Visually AcceSIble Rembrandt Images) Magnetic Resonance (MR) Imaging features for differentiation of glioblastoma (GBM) and brain metastasis (BM) of different primary tumors. Materials and methods T1-weighted pre- and post-contrast, T2-weighted, and T2-weighted, fluid attenuated inversion recovery (FLAIR) MR images of a total of 239 lesions from 109 patients with either GBM or BM (breast cancer, non-small cell (NSCLC) adenocarcinoma, NSCLC squamous cell...
1 CitationsSource
#1Sidong Liu (Macquarie University)H-Index: 17
#2Zubair Shah (Macquarie University)H-Index: 10
Last. Antonio Di Ieva (Macquarie University)H-Index: 26
view all 8 authors...
Mutations in isocitrate dehydrogenase genes IDH1 and IDH2 are frequently found in diffuse and anaplastic astrocytic and oligodendroglial tumours as well as in secondary glioblastomas. As IDH is a very important prognostic, diagnostic and therapeutic biomarker for glioma, it is of paramount importance to determine its mutational status. The haematoxylin and eosin (H&E) staining is a valuable tool in precision oncology as it guides histopathology-based diagnosis and proceeding patient’s treatment....
71 CitationsSource
#1Djuno I van Lent (UU: Utrecht University)H-Index: 1
#2Kirsten M van Baarsen (UU: Utrecht University)H-Index: 3
Last. Pierre Robe (UU: Utrecht University)H-Index: 27
view all 4 authors...
Background Isocitrate dehydrogenase (IDH) mutation and 1p/19q-codeletion are oncogenetic alterations with a positive prognostic value for diffuse gliomas, especially grade II and III. Some studies have suggested differences in biological behavior as reflected by radiological characteristics. In this paper, the literature regarding radiological characteristics in grade II and III glioma subtypes was systematically evaluated and a meta-analysis was performed. Methods Studies that addressed the rel...
3 CitationsSource